T1	Outcomes 204 214	recurrence
T2	Outcomes 971 992	endoscopic recurrence
T3	Outcomes 1127 1173	The primary endpoint was endoscopic recurrence
T4	Outcomes 1787 1816	months, endoscopic recurrence
T5	Outcomes 1921 1930	(p=0.03).
T6	Outcomes 1931 1957	Complete mucosal normality
T7	Outcomes 2120 2137	months recurrence
T8	Outcomes 2193 2205	in remission
T9	Outcomes 2288 2306	therapy recurrence
T10	Outcomes 2530 2563	the risk of endoscopic recurrence
T11	Outcomes 2565 2624	The incidence and type of adverse and severe adverse events
T12	Outcomes 2858 2888	to clinical risk of recurrence
T13	Outcomes 3013 3056	of postoperative Crohn's disease recurrence
T14	Outcomes 3150 3168	to disease control
T15	Outcomes 3209 3227	predict recurrence
T16	Outcomes 3259 3275	need monitoring.
T17	Outcomes 3276 3291	Early remission
